EU Says First COVID-19 Vaccinations Available By Year-End
Parliament To Hold Public Hearing On Access Issues
Executive Summary
A senior European Commission official has said that the first COVID-19 vaccinations are expected before the end of 2020, and confirmed that pharmaceutical companies developing vaccines will be liable for their products under existing laws.
You may also be interested in...
EU Politicians Squeeze Pharma Execs On Coronavirus Vaccine Contracts
With coronavirus cases again on the rise in many European countries, members of two EU parliamentary committees asked industry representatives to explain why details of COVID-19 vaccine supply agreements are being kept under wraps.
Coronavirus Notebook: EMA Expects First Vaccine Efficacy Data Soon, ACT-Accelerator Needs Urgent Funding
Talks are continuing on COVID-19 vaccine supply in the EU, with Pfizer/BioNTech’s BNT-162 the latest in the frame for the delivery of 200 million doses. The European Commission has also said that if the vaccines fail to perform, any money paid in advance purchase deals should go towards further research.
No Blanket Immunity For COVID-19 Vaccine Liabilities, Says EU
As the race to develop COVID-19 vaccines continues, EU member states are ready to financially cover certain of the companies’ risks, but not to change the rules on liability. Transparency proponents are calling for all contracts on vaccine purchases to be made public.